Medibio (MEB) Stock Price, News & Analysis

Company Overview

Medibio Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is based in Mount Lawley, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.26 million shs
• Average Volume: N/A
• Market Capitalization: A$4.55 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: ASX:MEB
• CIK: N/A
• Web: www.medibio.com.au
• Phone: 952-222-0551
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$3.07 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -46.56%
• Return on Assets: -13.16%

Debt

• Debt-to-Equity Ratio: 1.65
• Current Ratio: 0.17
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: A$1.01 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 3.50
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 6,100,000,000
• Free Float: N/A
• Market Cap: A$4.55 million
• Optionable: Not Optionable
• Beta: 0.62